The FDA is asking drug manufacturers to remove black box warnings on hormone replacement therapy for menopause, which could make it easier for women to access the treatment.

Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the Food and Drug Adm...

In its formal comment, the American College of Obstetrics and Gynecology, or ACOG, wrote that it has "long encouraged" the agency to reevaluate warning labels on low-dose estrogen products administere...